Ista Pharma price target raised by Jefferies

Ista Pharmaceuticals Inc. was maintained by Jefferies & Co. analyst David Windley at a buy rating and the price target on the stock was raised to $8.75 per share from $7.50 following second-quarter results. Ista Pharma shares Friday dropped $0.58, or 6.13%, to close at $8.88 on volume of 351,242 shares versus the three-month running average of 167,928 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.